Youssoufian Hagop 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jul 18, 2011
Insider Transaction Report
Form 4
Youssoufian Hagop
Executive VP, CMO
Transactions
- Award
Common Stock
2011-07-15+50,000→ 50,000 total - Disposition to Issuer
Stock Options (right to buy)
2011-07-15+250,000→ 250,000 totalExercise: $5.89Exp: 2021-07-15→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Grant of restricted stock; restrictions lapse on 7/15/2012.
- [F2]Option vests as follows: 83,333 shares on each of 7/15/2012 and 7/15/2013; 83,334 shares on 7/15/2014.